|
DE69838172T2
(de)
|
1997-08-22 |
2008-04-10 |
Astrazeneca Ab |
Oxindolylchinazolinderivate als angiogenesehemmer
|
|
EP1006113A1
(en)
|
1998-12-02 |
2000-06-07 |
Pfizer Products Inc. |
Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use to inhibit abnormal cell growth
|
|
UA71945C2
(en)
|
1999-01-27 |
2005-01-17 |
Pfizer Prod Inc |
Substituted bicyclic derivatives being used as anticancer agents
|
|
GB9918057D0
(en)
*
|
1999-07-30 |
1999-10-06 |
Univ Bristol |
Therapeutic agents
|
|
UA74803C2
(uk)
|
1999-11-11 |
2006-02-15 |
Осі Фармасьютікалз, Інк. |
Стійкий поліморф гідрохлориду n-(3-етинілфеніл)-6,7-біс(2-метоксіетокси)-4-хіназолінаміну, спосіб його одержання (варіанти) та фармацевтичне застосування
|
|
GB0010757D0
(en)
*
|
2000-05-05 |
2000-06-28 |
Astrazeneca Ab |
Chemical compounds
|
|
BR0111377A
(pt)
*
|
2000-06-06 |
2003-06-03 |
Pfizer Prod Inc |
Derivados de tiofeno úteis como agentes anticancerìgenos
|
|
US20030207878A1
(en)
*
|
2000-08-09 |
2003-11-06 |
Hennequin Lawrent Francois Andre |
Chemical compounds
|
|
PL359920A1
(en)
|
2000-09-20 |
2004-09-06 |
Merck Patent Gmbh |
4-amino-quinazolines
|
|
US6503914B1
(en)
|
2000-10-23 |
2003-01-07 |
Board Of Regents, The University Of Texas System |
Thienopyrimidine-based inhibitors of the Src family
|
|
AUPR213700A0
(en)
*
|
2000-12-18 |
2001-01-25 |
Biota Scientific Management Pty Ltd |
Antiviral agents
|
|
KR20020051675A
(ko)
*
|
2000-12-23 |
2002-06-29 |
이상남 |
4-페닐아미노티에노 [3,2-디] 피리미딘 유도체 및 이의제조방법
|
|
NZ527302A
(en)
|
2001-01-05 |
2006-10-27 |
Abgenix Inc |
Antibodies to insulin-like growth factor I receptor
|
|
ES2263743T3
(es)
*
|
2001-04-13 |
2006-12-16 |
Pfizer Products Inc. |
Derivados de 4-aminopiridopirimidina sustituidos con un grupo biciclico.
|
|
WO2003000194A2
(en)
|
2001-06-21 |
2003-01-03 |
Pfizer Inc. |
Thienopyridine and thienopyrimidine anticancer agents
|
|
US7829566B2
(en)
|
2001-09-17 |
2010-11-09 |
Werner Mederski |
4-amino-quinazolines
|
|
AR039067A1
(es)
|
2001-11-09 |
2005-02-09 |
Pfizer Prod Inc |
Anticuerpos para cd40
|
|
WO2003053446A1
(en)
*
|
2001-12-19 |
2003-07-03 |
Smithkline Beecham Corporation |
Thienopyrimidine compounds as protein tyrosine kinase inhibitors
|
|
WO2003055890A1
(en)
*
|
2001-12-21 |
2003-07-10 |
Bayer Pharmaceuticals Corporation |
Thienopyrimidine derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
|
|
EP1465900B1
(en)
*
|
2002-01-10 |
2008-05-14 |
Bayer HealthCare AG |
Rho-kinase inhibitors
|
|
CA2473910C
(en)
|
2002-01-23 |
2011-03-15 |
Bayer Pharmaceuticals Corporation |
Pyrimidine derivatives as rho-kinase inhibitors
|
|
MXPA04007191A
(es)
|
2002-01-23 |
2005-03-31 |
Bayer Pharmaceuticals Corp |
Derivados de pirimidina como inhibidores de rho-quinasa.
|
|
WO2003064428A1
(en)
*
|
2002-01-29 |
2003-08-07 |
H. Lundbeck A/S |
Furano- and thienopyrimidines as neurokinase inhibitors
|
|
US7071190B2
(en)
|
2002-02-15 |
2006-07-04 |
Rigel Pharmaceuticals, Inc. |
Inhibitors to tubulin polymerization
|
|
US20030225273A1
(en)
*
|
2002-03-21 |
2003-12-04 |
Michaelides Michael R. |
Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
|
|
UA77303C2
(en)
|
2002-06-14 |
2006-11-15 |
Pfizer |
Derivatives of thienopyridines substituted by benzocondensed heteroarylamide useful as therapeutic agents, pharmaceutical compositions and methods for their use
|
|
ATE323702T1
(de)
|
2002-08-06 |
2006-05-15 |
Astrazeneca Ab |
Kondensierte pyridine und pyrimidine mit tie2 (tek) aktivität
|
|
AR042052A1
(es)
*
|
2002-11-15 |
2005-06-08 |
Vertex Pharma |
Diaminotriazoles utiles como inhibidores de proteinquinasas
|
|
CL2003002287A1
(es)
|
2002-11-25 |
2005-01-14 |
Wyeth Corp |
COMPUESTOS DERIVADOS DE TIENO[3,2-b]-PIRIDINA-6-CARBONITRILOS Y TIENEO[2,3-b]-PIRIDINA-5-CARBONITRILOS, COMPOSICION FARMACEUTICA, PROCEDIMIENTO DE PREPARACION Y COMPUESTOS INTERMEDIARIOS, Y SU USO EN EL TRATAMIENTO DEL CANCER, APOPLEJIA, OSTEOPOROSIS
|
|
US7276519B2
(en)
|
2002-11-25 |
2007-10-02 |
Wyeth |
Thieno[3,2-b]pyridine-6-carbonitriles and thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors
|
|
AU2003286321A1
(en)
|
2002-12-19 |
2004-07-14 |
Pfizer Inc. |
2-(1h-indazol-6-ylamino)-benzamide compounds as protein kinases inhibitors useful for the treatment of ophtalmic diseases
|
|
SI1625121T1
(sl)
|
2002-12-20 |
2010-04-30 |
Pfizer Prod Inc |
Derivati pirimidina za zdravljenje abnormalne rasti celic
|
|
PT2476667E
(pt)
|
2003-02-26 |
2014-09-18 |
Sugen Inc |
Compostos de aminoheteroarilo como inibidores da proteína quinase
|
|
JP4712702B2
(ja)
*
|
2003-07-24 |
2011-06-29 |
バイエル・シエリング・フアーマ・アクチエンゲゼルシヤフト |
高増殖性疾患を処置するために有用な置換されたテトラヒドロベンゾチエノピリミジンアミン化合物
|
|
HN2004000285A
(es)
|
2003-08-04 |
2006-04-27 |
Pfizer Prod Inc |
ANTICUERPOS DIRIGIDOS A c-MET
|
|
ATE455546T1
(de)
*
|
2003-08-06 |
2010-02-15 |
Vertex Pharma |
Aminotriazol-verbindungen als proteinkinase- hemmer
|
|
US7501427B2
(en)
|
2003-08-14 |
2009-03-10 |
Array Biopharma, Inc. |
Quinazoline analogs as receptor tyrosine kinase inhibitors
|
|
JP4828421B2
(ja)
|
2003-08-14 |
2011-11-30 |
アレイ バイオファーマ、インコーポレイテッド |
受容体チロシンキナーゼ阻害剤としてのキナゾリン誘導体
|
|
WO2005021554A1
(en)
|
2003-08-29 |
2005-03-10 |
Pfizer Inc. |
Thienopyridine-phenylacet amides and their derivatives useful as new anti-angiogenic agents
|
|
AR045563A1
(es)
|
2003-09-10 |
2005-11-02 |
Warner Lambert Co |
Anticuerpos dirigidos a m-csf
|
|
US7332521B2
(en)
*
|
2003-09-25 |
2008-02-19 |
Wyeth |
Substituted indoles
|
|
US7419978B2
(en)
|
2003-10-22 |
2008-09-02 |
Bristol-Myers Squibb Company |
Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors
|
|
AP2006003619A0
(en)
|
2003-12-23 |
2006-06-30 |
Pfizer |
Novel quinoline derivatives
|
|
US7470712B2
(en)
*
|
2004-01-21 |
2008-12-30 |
Bristol-Myers Squibb Company |
Amino-benzazoles as P2Y1 receptor inhibitors
|
|
US20080242681A1
(en)
*
|
2004-01-22 |
2008-10-02 |
Altana Pharma Ag |
N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase Inhibitors
|
|
JP4842929B2
(ja)
*
|
2004-05-27 |
2011-12-21 |
ファイザー・プロダクツ・インク |
癌治療に有用なピロロピリミジン誘導体
|
|
GB0412467D0
(en)
*
|
2004-06-04 |
2004-07-07 |
Astrazeneca Ab |
Chemical compounds
|
|
US20050288290A1
(en)
*
|
2004-06-28 |
2005-12-29 |
Borzilleri Robert M |
Fused heterocyclic kinase inhibitors
|
|
ES2328601T3
(es)
|
2004-06-28 |
2009-11-16 |
Bayer Schering Pharma Ag |
Pirimidinas 4,6-disustituidas y su uso como inhibidores de proteina cinasa.
|
|
CN101014365B
(zh)
|
2004-07-16 |
2011-04-13 |
辉瑞产品公司 |
使用抗-igf-1r抗体联合治疗非血液的恶性肿瘤
|
|
EP1781664B1
(en)
*
|
2004-07-30 |
2013-09-04 |
MethylGene Inc. |
Inhibitors of vegf receptor and hgf receptor signaling
|
|
JP4242911B2
(ja)
|
2004-08-26 |
2009-03-25 |
ファイザー・インク |
プロテインキナーゼ阻害薬としてのエナンチオピュアなアミノヘテロアリール化合物
|
|
GB0423653D0
(en)
*
|
2004-10-25 |
2004-11-24 |
Piramed Ltd |
Pharmaceutical compounds
|
|
RU2007119637A
(ru)
*
|
2004-10-28 |
2008-12-10 |
Айрм Ллк (Bm) |
Соединения и композиции в качестве модуляторов hedgehog-пути
|
|
US7576080B2
(en)
*
|
2004-12-23 |
2009-08-18 |
Memory Pharmaceuticals Corporation |
Certain thienopyrimidine derivatives as phosphodiesterase 10 inhibitors
|
|
AU2006207712A1
(en)
*
|
2005-01-19 |
2006-07-27 |
F. Hoffmann-La Roche Ag |
5-aminoindole derivatives
|
|
WO2006101925A2
(en)
|
2005-03-16 |
2006-09-28 |
Osi Pharmaceuticals, Inc. |
Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors
|
|
EP3300739A3
(en)
|
2005-03-31 |
2018-07-18 |
Agensys, Inc. |
Antibodies and related molecules that bind to 161p2f10b proteins
|
|
EP1877444A2
(en)
|
2005-04-26 |
2008-01-16 |
Pfizer, Inc. |
P-cadherin antibodies
|
|
MX2007014617A
(es)
*
|
2005-05-20 |
2008-02-11 |
Methylgene Inc |
Inhibidores de senalizacion de receptor de factor de crecimiento endotelial bascular y receptor de factor de crecimiento de hepatocitos.
|
|
WO2008041053A2
(en)
|
2005-05-20 |
2008-04-10 |
Methylgene, Inc. |
Inhibitors of vegf receptor and hgf receptor signaling
|
|
US20060281768A1
(en)
*
|
2005-06-10 |
2006-12-14 |
Gaul Michael D |
Thienopyrimidine and thienopyridine kinase modulators
|
|
AU2006261082B2
(en)
*
|
2005-06-22 |
2012-04-19 |
Boehringer Ingelheim International Gmbh |
Thienopyrimidines for pharmaceutical compositions
|
|
US7608592B2
(en)
|
2005-06-30 |
2009-10-27 |
Virobay, Inc. |
HCV inhibitors
|
|
AR055625A1
(es)
*
|
2005-09-02 |
2007-08-29 |
Pfizer |
Procedimientos mejorados para preparar derivados de tienopiridinas heteroaril amida benzocondensados
|
|
SI2447283T1
(sl)
|
2005-09-07 |
2015-12-31 |
Amgen Fremont Inc. |
Človeška monoklonska protitelesa proti aktivin receptorski kinazi-1 (ALK-1)
|
|
AU2006292278B2
(en)
|
2005-09-20 |
2012-03-08 |
Osi Pharmaceuticals, Inc. |
Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
|
|
AR056200A1
(es)
*
|
2005-09-27 |
2007-09-26 |
Wyeth Corp |
Tieno [2,3-b]piridin-5-carbonitrilos como inhibidores de proteina quinasa
|
|
US20070213305A1
(en)
*
|
2005-11-02 |
2007-09-13 |
Cytovia, Inc. |
N-alkyl-N-aryl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
|
|
US20070099877A1
(en)
*
|
2005-11-02 |
2007-05-03 |
Cytovia, Inc. |
N-aryl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
|
|
WO2007056208A2
(en)
*
|
2005-11-02 |
2007-05-18 |
Cytovia, Inc. |
N-arylalkyl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
|
|
DE602006021645D1
(de)
|
2005-11-15 |
2011-06-09 |
Array Biopharma Inc |
Verfahren und Zwischenverbindungen zur Herstellung von N4-Phenyl-Quinazolin-4-Amin Derivaten
|
|
US8003662B2
(en)
*
|
2006-01-30 |
2011-08-23 |
Array Biopharma, Inc. |
Heterobicyclic thiophene compounds and methods of use
|
|
WO2007107005A1
(en)
*
|
2006-03-22 |
2007-09-27 |
Methylgene, Inc. |
Inhibitors of protein tyrosine kinase activity
|
|
US8008481B2
(en)
|
2006-03-31 |
2011-08-30 |
Ericsson Anna M |
Indazole compounds
|
|
CA2651898A1
(en)
*
|
2006-04-07 |
2007-10-18 |
Develogen Aktiengesellschaft |
Thienopyrimidines having mnk1/mnk2 inhibiting activity for pharmaceutical compositions
|
|
EA200802058A1
(ru)
|
2006-05-09 |
2009-06-30 |
Пфайзер Продактс Инк. |
Производные циклоалкиламинокислот и их фармацевтические композиции
|
|
EP1889847A1
(en)
|
2006-07-10 |
2008-02-20 |
DeveloGen Aktiengesellschaft |
Pyrrolopyrimidines for pharmaceutical compositions
|
|
US7750007B2
(en)
|
2006-11-06 |
2010-07-06 |
Supergen, Inc. |
Imidazo[1,2-beta]pyridazine and pyrazolo[1,5-alpha]pyrimidine derivatives and their use as protein kinase inhibitors
|
|
PE20081679A1
(es)
|
2006-12-07 |
2008-12-18 |
Hoffmann La Roche |
Compuestos del inhibidor de fosfoinositida 3-cinasa y metodos de uso
|
|
CA2710051C
(en)
*
|
2006-12-29 |
2017-05-16 |
Rigel Pharmaceuticals, Inc. |
Substituted triazoles useful as axl inhibitors
|
|
WO2008082839A2
(en)
*
|
2006-12-29 |
2008-07-10 |
Abbott Laboratories |
Pim kinase inhibitors as cancer chemotherapeutics
|
|
US20080161254A1
(en)
*
|
2007-01-03 |
2008-07-03 |
Virobay, Inc. |
Hcv inhibitors
|
|
ATE510841T1
(de)
*
|
2007-06-12 |
2011-06-15 |
Hoffmann La Roche |
Thiazoliopyrimidine und ihre verwendung als hemmer der phosphatidylinositol-3 kinase
|
|
EP2014662A1
(de)
*
|
2007-07-12 |
2009-01-14 |
Bayer Schering Pharma Aktiengesellschaft |
Indolylalkylthienopyrimidylamine als Modulatoren des EP2-Rezeptors
|
|
EP2014663A1
(de)
*
|
2007-07-12 |
2009-01-14 |
Bayer Schering Pharma AG |
Thienopyrimidylamine als Modulatoren des EP2-Rezeptors
|
|
CN101932587A
(zh)
*
|
2007-09-24 |
2010-12-29 |
吉宁特有限公司 |
噻唑并嘧啶pi3k抑制剂化合物及使用方法
|
|
JP5538231B2
(ja)
*
|
2007-10-18 |
2014-07-02 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ジヒドロチエノ［３，２−ｄ］ピリミジンおよびその中で使用される中間体の調製
|
|
WO2009055730A1
(en)
|
2007-10-25 |
2009-04-30 |
Genentech, Inc. |
Process for making thienopyrimidine compounds
|
|
KR20100108337A
(ko)
*
|
2007-11-15 |
2010-10-06 |
베링거 인겔하임 인터내셔날 게엠베하 |
사람 면역결핍 바이러스 복제의 억제제
|
|
BRPI0819453A2
(pt)
*
|
2007-11-28 |
2014-10-07 |
Dana Farber Cancer Inst Inc |
Composto, métodos para tratar um distúrbio relacionado com atividade de cinase, para tratar câncer em um paciente, para inibir a atividade de cinase e para identificar um composto que modula a atividade de cinase de bcr-abl, composição farmacêutica, e, kit
|
|
GEP20125574B
(en)
*
|
2008-01-11 |
2012-07-10 |
Glenmark Pharmaceuticals Sa |
Fused pyrimidine derivatives as trpv3 modulators
|
|
CA2713108A1
(en)
|
2008-02-07 |
2009-08-13 |
Virobay, Inc. |
Inhibitors of cathepsin b
|
|
MX2010009729A
(es)
|
2008-03-05 |
2010-12-21 |
Methylgene Inc |
Inhibidores de actividad de proteina tirosina quinasa.
|
|
US8119647B2
(en)
*
|
2008-04-23 |
2012-02-21 |
Glenmark Pharmaceuticals S.A. |
Fused pyrimidineone compounds as TRPV3 modulators
|
|
BRPI0918971A2
(pt)
|
2008-08-26 |
2015-12-01 |
Boehringer Ingelheim Int |
tienopirimidinas para composições farmacêuticas
|
|
CA2737597C
(en)
|
2008-10-16 |
2017-03-14 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof
|
|
KR101126736B1
(ko)
*
|
2008-11-27 |
2012-04-12 |
주식회사 레고켐 바이오사이언스 |
티로신 키나아제 저해 화합물, 이의 이성질체 또는 이의 약학적으로 허용가능한 염 및 이를 포함하는 약학적 조성물
|
|
SG172857A1
(en)
|
2009-02-09 |
2011-08-29 |
Supergen Inc |
Pyrrolopyrimidinyl axl kinase inhibitors
|
|
US20120189641A1
(en)
|
2009-02-25 |
2012-07-26 |
OSI Pharmaceuticals, LLC |
Combination anti-cancer therapy
|
|
US20110171124A1
(en)
|
2009-02-26 |
2011-07-14 |
Osi Pharmaceuticals, Inc. |
In situ methods for monitoring the EMT status of tumor cells in vivo
|
|
WO2010098866A1
(en)
|
2009-02-27 |
2010-09-02 |
Supergen, Inc. |
Cyclopentathiophene/cyclohexathiophene dna methyltransferase inhibitors
|
|
JP2012519282A
(ja)
|
2009-02-27 |
2012-08-23 |
オーエスアイ・ファーマシューティカルズ，エルエルシー |
間葉様腫瘍細胞またはその生成を阻害する薬剤を同定するための方法
|
|
US8642834B2
(en)
|
2009-02-27 |
2014-02-04 |
OSI Pharmaceuticals, LLC |
Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
|
|
WO2010099138A2
(en)
|
2009-02-27 |
2010-09-02 |
Osi Pharmaceuticals, Inc. |
Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
|
|
JP5709766B2
(ja)
|
2009-03-12 |
2015-04-30 |
ジェネンテック， インコーポレイテッド |
造血器腫瘍の治療のためのホスホイノシチド３キナーゼ阻害剤化合物と化学療法剤の併用
|
|
SG182247A1
(en)
*
|
2009-05-27 |
2012-08-30 |
Hoffmann La Roche |
Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
|
|
MX2011012520A
(es)
|
2009-05-27 |
2011-12-12 |
Hoffmann La Roche |
Compuestos inhibidores de pi3k de pirimidina biciclicos selectivos para p110 delta y metodos de uso de los mismos.
|
|
SG177640A1
(en)
|
2009-07-13 |
2012-02-28 |
Genentech Inc |
Diagnostic methods and compositions for treatment of cancer
|
|
WO2011014726A1
(en)
|
2009-07-31 |
2011-02-03 |
Osi Pharmaceuticals, Inc. |
Mtor inhibitor and angiogenesis inhibitor combination therapy
|
|
US20120157471A1
(en)
|
2009-09-01 |
2012-06-21 |
Pfizer Inc. |
Benzimidazole derivatives
|
|
RU2012114094A
(ru)
|
2009-09-11 |
2013-10-20 |
Дженентек, Инк. |
Способ идентификации пациента с увеличенной вероятностью ответа на противораковый агент
|
|
KR101557545B1
(ko)
|
2009-09-17 |
2015-10-06 |
에프. 호프만-라 로슈 아게 |
암 환자에서 진단 용도를 위한 방법 및 조성물
|
|
WO2011073521A1
(en)
|
2009-12-15 |
2011-06-23 |
Petri Salven |
Methods for enriching adult-derived endothelial progenitor cells and uses thereof
|
|
ES2607806T5
(es)
|
2010-02-12 |
2024-10-07 |
Pfizer |
Sales y polimorfos de 8-fluoro-2-{4-[(metilamino}metil]fenil}-1,3,4,5-tetrahidro-6H-azepino[5,4,3-cd]indol-6-ona
|
|
ES2562959T3
(es)
|
2010-02-26 |
2016-03-09 |
Evotec International Gmbh |
Tienopirimidinas que contienen un grupo alquilo sustituido para composiciones farmacéuticas
|
|
MX2012009735A
(es)
|
2010-02-26 |
2012-09-12 |
Boehringer Ingelheim Int |
4-[cicloalquiloxi (hetero) arilamino] tieno [2,3-d] pirimidinas que tienen actividad inhibitoria de mnk1/mnk2 para composiciones farmaceuticas.
|
|
UY33241A
(es)
|
2010-02-26 |
2011-09-30 |
Boehringer Ingelheim Int |
?Tienopirimidinas que contienen heterocicloalquilo para composiciones farmacéuticas?.
|
|
AU2011223655A1
(en)
|
2010-03-03 |
2012-06-28 |
OSI Pharmaceuticals, LLC |
Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
|
|
AU2011223643A1
(en)
|
2010-03-03 |
2012-06-28 |
OSI Pharmaceuticals, LLC |
Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
|
|
KR20130058672A
(ko)
|
2010-04-16 |
2013-06-04 |
제넨테크, 인크. |
ＰＩ3Ｋ/ＡＫＴ 키나제 경로 억제제 효능에 대한 예측 바이오마커로서의 ＦＯＸＯ３ａ
|
|
CN102250112A
(zh)
*
|
2010-05-18 |
2011-11-23 |
上海再启生物技术有限公司 |
7-溴-4-氨基噻吩并嘧啶的制备方法
|
|
EP2578590B1
(en)
*
|
2010-05-26 |
2017-08-16 |
Korea Institute of Science and Technology |
Anti-inflammatory compound having inhibitory activity against multiple tyrosine kinases, and pharmaceutical composition containing same
|
|
WO2011149126A1
(ko)
*
|
2010-05-26 |
2011-12-01 |
한국과학기술연구원 |
타이로신 카이네이즈 저해능을 가지는 항염증 화합물을 포함하는 약학적 조성물
|
|
WO2011153224A2
(en)
|
2010-06-02 |
2011-12-08 |
Genentech, Inc. |
Diagnostic methods and compositions for treatment of cancer
|
|
CN103068851B
(zh)
|
2010-06-16 |
2015-03-11 |
高等教育联邦系统-匹兹堡大学 |
内质蛋白的抗体及其用途
|
|
EP2594566A4
(en)
|
2010-07-16 |
2014-10-01 |
Kyowa Hakko Kirin Co Ltd |
AROMATIC HETEROCYCLIC NITROGEN CYCLE DERIVATIVE
|
|
CN104634971A
(zh)
|
2010-07-19 |
2015-05-20 |
霍夫曼-拉罗奇有限公司 |
鉴定响应抗癌疗法的可能性升高的患者的方法
|
|
WO2012010549A1
(en)
|
2010-07-19 |
2012-01-26 |
F. Hoffmann-La Roche Ag |
Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy
|
|
SG187592A1
(en)
|
2010-07-23 |
2013-03-28 |
Univ Boston |
Anti-despr inhibitors as therapeutics for inhibition of pathological angiogenesis and tumor cell invasiveness and for molecular imaging and targeted delivery
|
|
EP2616441B1
(en)
|
2010-09-17 |
2019-08-07 |
Purdue Pharma L.P. |
Pyridine compounds and the uses thereof
|
|
WO2012042421A1
(en)
|
2010-09-29 |
2012-04-05 |
Pfizer Inc. |
Method of treating abnormal cell growth
|
|
US9056865B2
(en)
|
2010-10-20 |
2015-06-16 |
Pfizer Inc. |
Pyridine-2-derivatives as smoothened receptor modulators
|
|
US20140004209A1
(en)
|
2010-12-22 |
2014-01-02 |
Genentech, Inc. |
Autophagy inducer and inhibitor combination therapy for the treatment of neoplasms
|
|
JP5813785B2
(ja)
|
2011-02-04 |
2015-11-17 |
デュケイン ユニバーシティー オブ ザ ホリー スピリット |
抗チューブリン活性を有する二環式および三環式のピリミジンチロシンキナーゼ阻害剤ならびに患者の処置方法
|
|
WO2012116040A1
(en)
|
2011-02-22 |
2012-08-30 |
OSI Pharmaceuticals, LLC |
Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors in hepatocellular carcinoma
|
|
WO2012142164A1
(en)
|
2011-04-12 |
2012-10-18 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Human monoclonal antibodies that bind insulin-like growth factor (igf) i and ii
|
|
US20140178368A1
(en)
|
2011-04-19 |
2014-06-26 |
Leslie Lynne SHARP |
Combinations of anti-4-1bb antibodies and adcc-inducing antibodies for the treatment of cancer
|
|
JP2014519813A
(ja)
|
2011-04-25 |
2014-08-21 |
オーエスアイ・ファーマシューティカルズ，エルエルシー |
癌薬剤発見、診断、および治療におけるｅｍｔ遺伝子シグネチャーの使用
|
|
US9056877B2
(en)
|
2011-07-19 |
2015-06-16 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
DK2734205T3
(en)
|
2011-07-21 |
2018-06-14 |
Tolero Pharmaceuticals Inc |
Heterocyclic Protein Kinase Inhibitors
|
|
MD20140023A2
(ro)
|
2011-09-22 |
2014-06-30 |
Pfizer Inc. |
Derivaţi de pirolpirimidină şi purină
|
|
ES2654160T3
(es)
|
2011-10-04 |
2018-02-12 |
Igem Therapeutics Limited |
Anticuerpos de IgE anti-HMW-MAA
|
|
CN103087077B
(zh)
*
|
2011-11-03 |
2016-05-18 |
上海希迈医药科技有限公司 |
噻吩并嘧啶和呋喃并嘧啶类衍生物、其制备方法及其在医药上的应用
|
|
MX2014005570A
(es)
|
2011-11-08 |
2014-05-30 |
Pfizer |
El uso de anticuerpos anti factor estimulante de la colonia de macrofagos para tratar trastornos inflamatorios.
|
|
JP6109193B2
(ja)
*
|
2012-01-10 |
2017-04-05 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
チエノピリミジン化合物
|
|
FR2988722B1
(fr)
|
2012-04-03 |
2014-05-09 |
Sanofi Sa |
Nouveaux derives de thienopyrimidines, leurs procedes de preparation et leurs utilisations therapeutiques
|
|
WO2013152252A1
(en)
|
2012-04-06 |
2013-10-10 |
OSI Pharmaceuticals, LLC |
Combination anti-cancer therapy
|
|
CN103360407B
(zh)
*
|
2012-04-10 |
2016-06-22 |
上海希迈医药科技有限公司 |
一种噻吩并嘧啶类衍生物、其制备方法及其在医药上的应用
|
|
CN103664991B
(zh)
*
|
2012-09-19 |
2016-12-28 |
中国科学院福建物质结构研究所 |
噻吩[2,3‑d]嘧啶衍生物、其制备方法及其用途
|
|
EP2909181B1
(en)
|
2012-10-16 |
2017-08-09 |
Tolero Pharmaceuticals, Inc. |
Pkm2 modulators and methods for their use
|
|
US9260426B2
(en)
|
2012-12-14 |
2016-02-16 |
Arrien Pharmaceuticals Llc |
Substituted 1H-pyrrolo [2, 3-b] pyridine and 1H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitors
|
|
RU2015140573A
(ru)
|
2013-02-25 |
2017-03-30 |
Дженентек, Инк. |
Способы и композиции для обнаружения и лечения устойчивого к лекарственным средствам мутанта акт
|
|
PT2970205T
(pt)
|
2013-03-14 |
2019-08-26 |
Tolero Pharmaceuticals Inc |
Inibidores da jak2 e da alk2 e métodos para a sua utilização
|
|
US9206188B2
(en)
|
2013-04-18 |
2015-12-08 |
Arrien Pharmaceuticals Llc |
Substituted pyrrolo[2,3-b]pyridines as ITK and JAK inhibitors
|
|
AR096654A1
(es)
|
2013-06-20 |
2016-01-27 |
Ab Science |
Derivados de benzimidazol como inhibidores selectivos de proteína quinasa
|
|
EP3052102B1
(en)
|
2013-10-04 |
2019-12-04 |
Aptose Biosciences Inc. |
Compositions for treating cancers
|
|
UA115388C2
(uk)
|
2013-11-21 |
2017-10-25 |
Пфайзер Інк. |
2,6-заміщені пуринові похідні та їх застосування в лікуванні проліферативних захворювань
|
|
EP4012049A3
(en)
|
2014-04-04 |
2022-08-24 |
Crown Bioscience, Inc. (Taicang) |
Methods for determining responsiveness to mek/erk inhibitors
|
|
WO2015155624A1
(en)
|
2014-04-10 |
2015-10-15 |
Pfizer Inc. |
Dihydropyrrolopyrimidine derivatives
|
|
HRP20192056T1
(hr)
|
2014-04-30 |
2020-02-21 |
Pfizer Inc. |
Derivati diheterocikla vezani na cikloalkil
|
|
WO2016001789A1
(en)
|
2014-06-30 |
2016-01-07 |
Pfizer Inc. |
Pyrimidine derivatives as pi3k inhibitors for use in the treatment of cancer
|
|
WO2016008011A1
(en)
*
|
2014-07-16 |
2016-01-21 |
Novogen ltd |
Functionalised and substituted indoles as anti-cancer agents
|
|
EP3177320B1
(en)
|
2014-07-31 |
2021-01-06 |
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services |
Human monoclonal antibodies against epha4 and their use
|
|
WO2016097918A1
(en)
|
2014-12-18 |
2016-06-23 |
Pfizer Inc. |
Pyrimidine and triazine derivatives and their use as axl inhibitors
|
|
AU2016252609B2
(en)
|
2015-04-20 |
2022-06-30 |
Sumitomo Pharma Oncology, Inc. |
Predicting response to alvocidib by mitochondrial profiling
|
|
CN107709344B
(zh)
|
2015-05-01 |
2022-07-15 |
共晶制药股份有限公司 |
用于治疗黄病毒科病毒和癌症的核苷类似物
|
|
HUE045585T2
(hu)
|
2015-05-18 |
2020-01-28 |
Tolero Pharmaceuticals Inc |
Megnövelt biológiai hozzáférhetõséggel rendelkezõ Alvocidib gyógyszer-elõanyagok
|
|
WO2017009751A1
(en)
|
2015-07-15 |
2017-01-19 |
Pfizer Inc. |
Pyrimidine derivatives
|
|
AU2016301315C1
(en)
|
2015-08-03 |
2022-07-07 |
Sumitomo Pharma Oncology, Inc. |
Combination therapies for treatment of cancer
|
|
WO2017096165A1
(en)
|
2015-12-03 |
2017-06-08 |
Agios Pharmaceuticals, Inc. |
Mat2a inhibitors for treating mtap null cancer
|
|
WO2017112777A1
(en)
|
2015-12-22 |
2017-06-29 |
SHY Therapeutics LLC |
Compounds for the treatment of cancer and inflammatory disease
|
|
EP3426653B1
(en)
*
|
2016-03-11 |
2021-12-15 |
AC Immune SA |
Bicyclic compounds for diagnosis and therapy
|
|
CN107652273B
(zh)
*
|
2016-07-26 |
2020-05-01 |
沈阳药科大学 |
嘧啶类衍生物及其制备方法和应用
|
|
WO2018094275A1
(en)
|
2016-11-18 |
2018-05-24 |
Tolero Pharmaceuticals, Inc. |
Alvocidib prodrugs and their use as protein kinase inhibitors
|
|
CA3047557A1
(en)
|
2016-12-19 |
2018-06-28 |
Tolero Pharmaceuticals, Inc. |
Profiling peptides and methods for sensitivity profiling
|
|
KR102736865B1
(ko)
|
2017-06-21 |
2024-12-03 |
샤이 테라퓨틱스 엘엘씨 |
암, 염증성 질환, 신경발달질환 및 섬유증 질환의 치료를 위하여 Ras 수퍼패밀리와 상호작용하는 화합물
|
|
JP7196160B2
(ja)
|
2017-09-12 |
2022-12-26 |
スミトモ ファーマ オンコロジー， インコーポレイテッド |
Ｍｃｌ－１阻害剤アルボシジブを用いた、ｂｃｌ－２阻害剤に対して非感受性である癌の治療レジメン
|
|
US20200237766A1
(en)
|
2017-10-13 |
2020-07-30 |
Tolero Pharmaceuticals, Inc. |
Pkm2 activators in combination with reactive oxygen species for treatment of cancer
|
|
KR20210038906A
(ko)
|
2018-07-26 |
2021-04-08 |
스미토모 다이니폰 파마 온콜로지, 인크. |
비정상적 acvr1 발현과 연관된 질환을 치료하는 방법 및 그에 사용하기 위한 acvr1 억제제
|
|
CN120040470A
(zh)
*
|
2018-11-20 |
2025-05-27 |
乔治敦大学 |
用于治疗神经退行性、肌退行性和溶酶体贮积病症的组合物和方法
|
|
US11034710B2
(en)
|
2018-12-04 |
2021-06-15 |
Sumitomo Dainippon Pharma Oncology, Inc. |
CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer
|
|
JP7407461B2
(ja)
|
2018-12-19 |
2024-01-04 |
シャイ・セラピューティクス・エルエルシー |
がん、炎症性疾患、ｒａｓ病、及び線維性疾患の処置のためのｒａｓスーパーファミリーと相互作用する化合物
|
|
ES2974634T3
(es)
|
2018-12-21 |
2024-06-28 |
Celgene Corp |
Inhibidores de tienopiridinas de RIPK2
|
|
HUE072069T2
(hu)
|
2019-02-12 |
2025-10-28 |
Sumitomo Pharma America Inc |
2-((1R,4R)-4-((3-(3-(trifluormetil)fenil)imidazo[1,2- b]piridazin-6-il)amino)ciklohexil)propán-2-ol sósavas sójának kristályos formája
|
|
AU2020222881C1
(en)
|
2019-02-13 |
2026-01-22 |
Ptc Therapeutics, Inc. |
Thioeno(3,2-b) pyridin-7-amine compounds for treating familial dysautonomia
|
|
WO2020167624A1
(en)
|
2019-02-13 |
2020-08-20 |
Ptc Therapeutics, Inc. |
Pyrrolo[2,3-d]pyrimidine compounds for treating familial dysautonomia
|
|
EP3929185A4
(en)
*
|
2019-02-19 |
2023-02-15 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
NITROGEN CONDENSED CYCLIC COMPOUND, METHOD OF PRODUCTION THEREOF AND USE THEREOF
|
|
WO2020180768A1
(en)
*
|
2019-03-01 |
2020-09-10 |
Revolution Medicines, Inc. |
Bicyclic heteroaryl compounds and uses thereof
|
|
JP2022525149A
(ja)
|
2019-03-20 |
2022-05-11 |
スミトモ ダイニッポン ファーマ オンコロジー， インコーポレイテッド |
ベネトクラクスが失敗した急性骨髄性白血病（ａｍｌ）の処置
|
|
AU2020245437A1
(en)
|
2019-03-22 |
2021-09-30 |
Sumitomo Pharma Oncology, Inc. |
Compositions comprising PKM2 modulators and methods of treatment using the same
|
|
WO2021057256A1
(zh)
*
|
2019-09-29 |
2021-04-01 |
四川科伦博泰生物医药股份有限公司 |
一种含氮并环类化合物，包含其的药物组合物，其制备方法及其用途
|
|
KR20220113700A
(ko)
*
|
2019-12-12 |
2022-08-16 |
피티씨 테라퓨틱스, 인크. |
가족성 자율신경실조증 치료를 위한 화합물
|
|
WO2021155006A1
(en)
|
2020-01-31 |
2021-08-05 |
Les Laboratoires Servier Sas |
Inhibitors of cyclin-dependent kinases and uses thereof
|
|
CN115746017B
(zh)
*
|
2022-11-30 |
2024-06-07 |
英维沃化工科技(广州)有限公司 |
一种噻吩并嘧啶类化合物及其制备方法和应用
|
|
CN118078831B
(zh)
*
|
2024-02-06 |
2026-06-09 |
中国科学院兰州化学物理研究所 |
一种小分子化合物在制备治疗胰腺癌药物中的应用
|